Molecular Templates, Inc.
DelistedCIK 1183765fmd_0P5QKJJXNF48FQHV7WX09HMSJHManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2001 to Jun 30, 2024, 66 periods
Latest annual · FY2019
Millions- Total revenues
- 22
- Operating income
- (10)
- Net income
- (8)
- Free cash flow
- (42)
Latest quarter · Q2 FY2024
Millions- Operating income
- (8)
- Net income
- (8)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2018 to FY2023
- n/m
Molecular Templates, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2023 | FY2022 | Change | Source |
|---|---|---|---|---|
| Operating income | -$10.5 million | -$88.9 million | 10-K 2024-03-29 · proof | |
| Net income | -$8.1 million | -$92.7 million | 10-K 2024-03-29 · proof | |
| Cash from operating activities | -$41.8 million | -$89 million | 10-K 2024-03-29 · proof | |
| Free cash flow | -$42 million | -$92.2 million | 10-K 2024-03-29 · proof | |
| Total assets | $35.4 million | $97.5 million | -63.7% | 10-K 2024-03-29 · proof |
| Total liabilities | $31.2 million | $112.7 million | -72.3% | 10-K 2024-03-29 · proof |
| Cash and cash equivalents | $11.5 million | $32.2 million | -64.2% | 10-K 2024-03-29 · proof |
- What was Molecular Templates, Inc.'s operating income in fiscal 2023?
- Molecular Templates, Inc. reported operating income of -$10.5 million for fiscal 2023 (the year ended Dec 31, 2023), against -$88.9 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2024. SEC
- What was Molecular Templates, Inc.'s net income in fiscal 2023?
- Molecular Templates, Inc. reported net income of -$8.1 million for fiscal 2023 (the year ended Dec 31, 2023), against -$92.7 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2024. SEC
- What was Molecular Templates, Inc.'s cash from operating activities in fiscal 2023?
- Molecular Templates, Inc. reported cash from operating activities of -$41.8 million for fiscal 2023 (the year ended Dec 31, 2023), against -$89 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2024. SEC
- What was Molecular Templates, Inc.'s free cash flow in fiscal 2023?
- Molecular Templates, Inc. reported free cash flow of -$42 million for fiscal 2023 (the year ended Dec 31, 2023), against -$92.2 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2024. SEC
- What are Molecular Templates, Inc.'s total assets?
- As of Dec 31, 2023, Molecular Templates, Inc. reported total assets of $35.4 million, against $97.5 million a year earlier (-63.7%). Source: the 10-K filed with the SEC on Mar 29, 2024. SEC
- What are Molecular Templates, Inc.'s total liabilities?
- As of Dec 31, 2023, Molecular Templates, Inc. reported total liabilities of $31.2 million, against $112.7 million a year earlier (-72.3%). Source: the 10-K filed with the SEC on Mar 29, 2024. SEC
- What are Molecular Templates, Inc.'s cash and cash equivalents?
- As of Dec 31, 2023, Molecular Templates, Inc. reported cash and cash equivalents of $11.5 million, against $32.2 million a year earlier (-64.2%). Source: the 10-K filed with the SEC on Mar 29, 2024. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1183765&period_type=annual&limit=5"Information only, not investment advice.